Cargando…

Role of IL-6 inhibitor in treatment of COVID-19-related cytokine release syndrome

Cytokine release syndrome (CRS) may be the key factor in the pathology of severe coronavirus disease 2019 (COVID-19). As a major driver in triggering CRS in patients with COVID-19, interleukin-6 (IL-6) appears to be a promising target for therapeutics. The results of inhibiting both trans- and class...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Peng, Geng, Jie, Wang, Feng, Chen, Xiaobo, Huang, Zhiwei, Wang, Yuliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893562/ https://www.ncbi.nlm.nih.gov/pubmed/33628091 http://dx.doi.org/10.7150/ijms.53564

Ejemplares similares

Perspectives on anti-IL-1 inhibitors as potential therapeutic interventions for severe COVID-19
por: Geng, Jie, et al.
Publicado: (2021)

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
por: Kang, Sujin, et al.
Publicado: (2020)

Role of IL-38 and Its Related Cytokines in Inflammation
por: Yuan, Xianli, et al.
Publicado: (2015)

The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
por: Wang, Jiasheng, et al.
Publicado: (2021)

Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: An Update and Concise Review
por: Chen, Xiaobo, et al.
Publicado: (2021)

In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease
por: Zongfei, Ji, et al.
Publicado: (2020)

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome
por: Rubsamen, Reid, et al.
Publicado: (2020)

Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures
por: Loppnow, Harald, et al.
Publicado: (2011)

Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2
por: Corominas, Hèctor, et al.
Publicado: (2021)

Cytokine release syndrome
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2018)

Immune Checkpoint Inhibitor-Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database
por: Ceschi, Alessandro, et al.
Publicado: (2020)

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
por: Liu, Bingwen, et al.
Publicado: (2020)

Emerging roles for the IL-6 family of cytokines in pancreatic cancer
por: van Duijneveldt, Gemma, et al.
Publicado: (2020)

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
por: Wang, Zhenguang, et al.
Publicado: (2018)

Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy
por: Ferreros, Puri, et al.
Publicado: (2022)

Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review)
por: Chen, Jia-Jie, et al.
Publicado: (2021)

Rituximab and Cytokine Release Syndrome
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2012)

Chromatin regulates IL-33 release and extracellular cytokine activity
por: Travers, Jared, et al.
Publicado: (2018)

Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series
por: Nakamura, Hideta, et al.
Publicado: (2020)

Levels of Inflammatory Cytokines IL-1β, IL-6, IL-8, IL-17A, and TNF-α in Aqueous Humour of Patients with Diabetic Retinopathy
por: Feng, Songfu, et al.
Publicado: (2018)

The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases
por: Kuwabara, Taku, et al.
Publicado: (2017)

“Small” Intestinal Immunopathology Plays a “Big” Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-γ, IL-17A, and a Janus Kinase Inhibitor
por: Kale, Shiv D., et al.
Publicado: (2020)

Urinary excretion of IL-1β, IL-6 and IL-8 cytokines during relapse and remission of idiopathic nephrotic syndrome
por: Al-Eisa, Amal A, et al.
Publicado: (2017)

The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer
por: Martínez-Pérez, Carlos, et al.
Publicado: (2021)

The Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
por: Abaurrea, Andrea, et al.
Publicado: (2021)

Effects of febuxostat on serum cytokines IL-1, IL-4, IL-6, IL-8, TNF-α and COX-2
por: Hao, Guohua, et al.
Publicado: (2019)

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
por: Hu, Yongxian, et al.
Publicado: (2022)

Cytokine Release Syndrome: Current Perspectives
por: Murthy, Hemant, et al.
Publicado: (2019)

Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
por: Qu, Ning, et al.
Publicado: (2013)

Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus
por: Zalinger, Zachary B., et al.
Publicado: (2017)

The role of synovial fluid cytokines IL-6, IL-23 and IL-17 in the pathogenesis and persistence of synovial inflammation in JIA patients
por: Tzimouli, V, et al.
Publicado: (2008)

The Role of IL-17 Cytokines in Psoriasis
por: Mosca, Megan, et al.
Publicado: (2021)

The Comparison of Inflammatory Cytokines (IL-6 and IL-18) and Immune Cells in Japanese Encephalitis Patients With Different Progression
por: Zhou, Yun, et al.
Publicado: (2022)

Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family
por: Sziksz, Erna, et al.
Publicado: (2015)

Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients
por: Altamura, Mario, et al.
Publicado: (2022)

Cytokine status and significant increase of IL-6 and sIL-6R in the aqueous humor of diabetic cataract patients revealed by quantitative multiplexed assays
por: Chen, Yan, et al.
Publicado: (2023)

Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10
por: Rong, Yu-Dong, et al.
Publicado: (2018)

IL-6/IFN-γ double knockdown CAR-T cells reduce the release of multiple cytokines from PBMCs in vitro
por: Zhang, Huihui, et al.
Publicado: (2022)

Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis
por: Chen, Xiao-Wu, et al.
Publicado: (2015)

Value of anal swabs for SARS-COV-2 detection: a literature review
por: Wang, Yuliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q9jcbhd12p21vrfo5p7m1jbf1u